Liu Xueke, Su Guoyang, Wu Boyuan, and Liu Lianlong agreed to acquire 21% stake in Xiamen Aomu Trade Co., Ltd from Fujian Aonong Biological Technology Group Incorporation Limited (SHSE:603363) for CNY 0 on January 12, 2018. Liu Xueke, Su Guoyang, Wu Boyuan, and Liu Lianlong will acquire 12% stake, 3% stake, 3% stake and 3% stake respectively. The transaction is subject to the Fujian Aonong Biological Technology shareholders’ approval. The transaction is approved by the Board of Fujian Aonong Biological Technology on January 12, 2018.